What is Mendel?
Founded in 2016 and headquartered in San Jose, California, Mendel operates at the intersection of artificial intelligence and healthcare. The company's core technology is an AI engine designed to meticulously scan and evaluate patient records. By leveraging this capability, Mendel aims to provide highly personalized care pathways for patients, addressing a critical need for more tailored medical treatments. The company's focus on data-driven insights positions it as a key player in the evolving landscape of digital health and personalized medicine.
How much funding has Mendel raised?
Mendel has raised a total of $42.1M across 3 funding rounds:
Other Financing Round
$2M
Debt
$150K
Series B
$40M
Other Financing Round (2017): $2M with participation from BootstrapLabs, LaunchCapital, SOSV, and DCM Ventures
Debt (2020): $150K led by PPP
Series B (2022): $40M supported by DCM Limited and Oak HC/FT
Key Investors in Mendel
BootstrapLabs
BootstrapLabs is a leading Venture Capital firm based in Silicon Valley and focused on Applied Artificial Intelligence. The firm invests in mission-driven founders who want to shape a better future by applying artificial intelligence to solve some of the world's most important and valuable opportunities.
LaunchCapital
LaunchCapital is a venture capital firm that supports entrepreneurs at the seed and early stages, providing hands-on assistance from the very beginning. Since its inception in 2008, it has invested in over 200 innovative companies across various industries.
Oak HC/FT
Founded in 2014, Oak HC/FT is the premier venture growth-equity fund investing in Healthcare Information & Services ("HC") and Financial Services Technology ("FT"). With $3.3 billion in assets under management, we are focused on driving transformation in these industries.
What's next for Mendel?
With the recent Series B financing and a substantial total funding amount, Mendel is poised for significant expansion and further development of its AI platform. The strategic investment signals strong confidence from its backers in Mendel's ability to scale its operations and deepen its impact on patient care. Future initiatives will likely involve enhancing its analytical capabilities, expanding its market reach, and forging new partnerships within the healthcare ecosystem. This capital will be instrumental in driving innovation and solidifying Mendel's position as a leader in AI-powered personalized healthcare solutions.
See full Mendel company page
